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Abstract
Background: Chikungunya virus (CHIKV) is a prevalent mosquito-borne pathogen that is emerging in many parts of
the globe causing significant human morbidity. Here, we report the isolation and characterization of an infectious
CHIKV from banked serum specimens of suspected patients from the 2009 epidemic in Thailand.
Methods: Standard plaque assay was used for CHIKV isolation from the banked serum specimens. Isolated CHIKV
was identified base on E1 structural gene sequence. Growth kinetic, infectivity, cell viability and cytokine gene
expression throughout CHIKV infection in a permissive cell line, 293T cells, was performed using several approaches,
including standard plaque assay, immunofluorescence assay, classical MTT assay, and quantitative real-time PCR.
Two tailed Student’s t test was used for evaluation statistically significance between the mean values of the groups.
Results: Based on the E1 structural gene sequence and phylogenetic analysis, we identified the virus as the
CHIK/SBY8/10 isolate from Indonesia. Assessment of the growth kinetics, cytopathic effects as well as its ability
to induce cellular immune responses suggested that the currently isolated CHIK/SBY8/10 virus is relatively more
virulent than a known CHIKV vaccine strain, which also induces more dramatic proinflammatory responses.
Conclusions: Our studies further add to the infectivity of a less-studied yet infectious CHIKV isolate as well as
underscored the importance and utility of 293T cells as an excellent cell culture model for studying viral growth,
CHIKV-induced inflammatory cellular responses and cell death. Together, these studies provide novel information
on the CHIKV biology, infectivity and virus-cell interaction, which would help develop novel interventions against
the infection.
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Background
First discovered in Tanzania in African continent in 1952
and later identified in Thailand in 1958, Chikungunya
virus (CHIKV) fever is a re-emerging public health prob-
lem with significant human morbidity, accounting for
approximately 1.4 million suspected cases worldwide [1].
Although the infection is most prevalent in Africa and
Asia, travellers from other continents can import the
infection locally, including in non-endemic areas; for
example, as of 2015, there were over 1,379,788 suspected
cases of CHIKV in North and South America including at
least 191 deaths [2]. CHIKV infection is caused by the
single-stranded, positive-strand RNA virus that is trans-
mitted by Aedes mosquitoes [3–6]. While A. aegypti was
long been considered as the only mosquito vector for
CHIKV, investigation in the 2005–2006 epidemic on
Reunion island that involved 266,000 human cases sug-
gested that a single mutation, an alanine-to-valine substi-
tution in the E1 envelope glycoprotein at the position 226
enabled virus acquisition by a new mosquito vector, A.
albopictus, commonly known as the Asian tiger mosquito,
which was implicated in that epidemic [7]. Due to already
established widespread distribution as well as increasing
global expansion of A. albopictus, the potential for CHIKV
to extend its range into the Western hemisphere is a real
possibility [8, 9]. Although CHIKV and dengue fever
manifest similar clinical symptoms and are transmitted by
the same mosquito vectors reflecting similar epidemiology
and geographical distribution [10], CHIKV is relatively
less studied and effective diagnostics and vaccines are
currently unavailable. Clinical manifestations following
CHIKV infection are also similar to those developed upon
Zika infection. A mild to severe joint pain is the hallmark
of CHIKV infection, and CHIKV is considered one of the
most prominent arthritogenic alphavirus. Although in-
tense Th2 cytokine responses are typically associated with
the infection [11], studies reported significant correlations
between cytokines, anti-CHIKV antibodies and clinical
features. The control of the virus during infection is
achieved through acquired immune responses; however,
the persistence of the virus in joint tissue is associated
with its pro-arthritogenic potential, likely inducing the
production of proinflammatory factors [12]. Despite these
studies, the mechanisms influencing immunopathogenesis
of CHIKV infection remains unclear [13, 14].
Approximately 11.8 kB RNA genome of CHIKV en-
codes four nonstructural proteins (nsP1–4) and a single
structural polyprotein, which after proteolytic process-
ing, generates three main structural proteins: the capsid
and the envelope glycoproteins E2 and E1, which exists
in the virion as a E1/E2 heterodimer [15, 16]. While E2
is responsible for viral attachment to target host cell, E1
is a class II viral fusion protein, which after dissociation
from E2, trimerizes and mediates fusion of viral and host
cellular membranes [17]. Sequence of Envelope E1 is often
used for phylogenetic analysis of CHIKV and is classified into
3 genetic lineages: Asian, West African, and East/Central/
South African (ECSA) genotypes [9, 18, 19]. The major out-
break of chikungunya fever in Thailand in 2008–2009, which
affected at least 50,000 people was caused by the ECSA
lineage virus [20]. Notably, since 2009, despite a large out-
break and more recent human cases, studies addressing
characterization of CHIKV clinical isolates in Thailand are
still very limited [21]. Here, we report the initial
characterization of a CHIKV clinical isolate purified from
banked serum specimens of suspected patients from the
2009 epidemic in Thailand. We sequenced the E1 structural
gene and characterized the isolated virus in a permissive cell
line, 293T cells. We examined the viral growth kinetics and
studied the cytopathic effects as well as assessed the ability of
the CHIKV isolate to induce cellular cytokine responses. To-
gether, these fundamental studies increase our knowledge of
CHIKV biology, virus-cell interaction and will help develop
novel interventions against the infection.
Methods
Cell cultures
The human embryonic kidney epithelial cell line 293T
(Invitrogen, Grand Island, NY, USA) was kindly provided
by Dr. Sansanee Noisakran, National Center for Genetic
Engineering and Biotechnology, Thailand. 293T cells
were cultured at 37 °C, 5 % CO2 in Dulbecco’s Modified
Eagle Medium (DMEM; Gibco, Invitrogen, USA) supple-
mented with 10 % heat-inactivated fetal bovine serum
(FBS; Gibco, Invitrogen, USA), 37 μg ml−1 of penicillin,
60 μg ml−1 of streptomycin, 25 mM HEPES, 2 mM L-
glutamine, and 0.37 % NaH2CO3. African green monkey
kidney Vero cell (American Type Culture Collection;
ATCC, Manassas, VA) and Aedes albopictus C6/36 cell
[22], were kindly provided by Ms. Tanapan Pruksamas,
National Center for Genetic Engineering and Biotech-
nology, Thailand. Vero cells were cultured at 37 °C, 5 %
CO2 in Minimum Essential Medium (MEM; Gibco, Invi-
trogen, USA) supplemented with 10 % heat-inactivated
FBS, and 37 μg ml−1 of penicillin, 60 μg ml−1 of strepto-
mycin. C6/36 cells were cultured at 28 °C in Leibovitz’s L-
15 medium (Gibco, Invitrogen, USA) supplemented with
10 % heat-inactivated FBS and 10 % tryptose-phosphate.
Virus isolation and propagation
Chikungunya viruses (CHIKVs) were isolated from five
patient sera collected from Songkhla Province, Thailand
from the 2009 outbreak using standard virology proce-
dures [7]. These sera were tested negative for the pres-
ence of dengue virus (DENV) and yellow fever virus, as
assessed by routine PCR analysis. A. albopictus C6/36
cells were inoculated with 200 μl of patient sera and in-
cubated at 28 °C. Cytopathic effects (CPE) were
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observed daily until appearance of 70–80 % CPE. Super-
natants were harvested and serially diluted from 10−1 to
10−4 in Leibovitz’s L-15 medium (Gibco, Invitrogen,
USA) supplemented with 2 % heat-inactivated FBS and
10 % tryptose-phosphate. Each diluted serum was added
to monolayer of A. albopictus C6/36 cells and gently agi-
tated at room temperature for 2 h. Supernatants were dis-
carded and the Leibovitz’s L-15 medium containing 3 %
agarose (Invitrogen, USA) was overlaid. The cells were in-
cubated at 28 °C and CPE were observed daily until ap-
pearance of single plaques. Single plaques were picked
and resuspended in MEM (Gibco, Invitrogen, USA) sup-
plemented with 2 % heat-inactivated FBS. The resus-
pended single plaques were inoculated in Vero cells and
gently agitated at room temperature for 2 h before incuba-
tion at 37 °C, 5 % CO2 for 7 days. CPE was observed daily
for 7 days. Infected Vero cell suspension at day 7 was ali-
quoted for confirmation of CHIKV using polymerase
chain reaction (PCR). The isolated CHIKV were propa-
gated in Vero cells as described above until the titer
reached about 4x107 pfu/ml and were harvested by sup-
plementing the infected Vero cell suspension with 20 %
heat-inactivated FBS before filtration through Millex-GP
filter (EMD Millipore, USA). The virus was kept at −80 °
C until performing subsequent experiments.
Standard plaque assay
CHIKV 181/clone 25 (herein abbreviated as V-181) was
kindly provided by Dr. Butsaya Thaisomboonsuk, the
Armed Forces Research Institute of Medical Sciences
(AFRIMS), Thailand. V-181 and the isolated CHIKV
were serially diluted in MEM (Gibco, Invitrogen, USA)
supplemented with 2 % heat-inactivated FBS. The dilu-
ents were inoculated three times in Vero cells and gently
agitated at room temperature for 2 h. Supernatants
were discarded and the MEM containing 0.3 % agarose
(Invitrogen, USA) was overlaid. The cells were incubated
at 37 °C, 5 % CO2 and CPE was daily observed until ap-
pearance of single plaques. Plaque number was counted
after fixation of the cells with 4 % formaldehyde and stain-
ing with 0.2 % crystal violet to visualized single plaques
clearly. The plaque number per millilitre was calculated.
Virus infection
Vero and 293T cells were grown until the cells reached
about 100 % confluence (approximately 1.5 × 106 and 5.6 ×
106 cells/ml). The V-181 isolate and the isolated CHIKV
were inoculated at a multiplicity of infection (MOI) of 10
in either the Vero or the 293T cells at room temperature
with gently agitation for 2 h. Supernatants were removed
and either infected Vero cell medium (MEM supple-
mented with 2 % heat-inactivated FBS) or infected 293T
cell medium (DMEM supplemented with 2 % heat-
inactivated FBS, 25 mM HEPES, 2 mM L-glutamine, and
0.37 % NaH2CO3) was added. The infected cells were incu-
bated at 37 °C, 5 % CO2 for further experiments.
Cytopathic effects
The cytopathic effects (CPE) of virus infection were studied
using published procedures [23]. Vero cells infected with
isolated CHIKV as described above were observed and
scored three times for CPE under light microscopy with 5
different fields for 7 days on a daily basis. A CHIKV that in-
duced the largest plaque size was selected for this study.
293T cells infected with either V-181 or the selected
CHIKV isolate (CHIK/SBY8/10 herein abbreviated as
T-SBY) were observed and scored three times for cyto-
pathic effects (CPE) under light microscopy in 5 different
fields for 10 days on a daily basis.
Polymerase chain reaction and sequencing
To confirm the identity of the isolated clone of CHIKV,
viral RNA from infected Vero cells from each clone were
extracted using High Pure Viral RNA Kit (Roche, USA).
RNA was used as a template for reverse-transcriptase
polymerase chain reaction (RT-PCR) using the RevertAid
First Strand cDNA Synthesis Kit (Thermo Fisher Scien-
tific, USA). Viral non-structural protein 1 gene (nsp1)
Table 1 List of primers used in this study for PCR and qRT-PCR
Primer Forward primer Reverse primer
CHIKV nsp1 5′-ccgctcgagtagagcaggaaattgatccc-3′ 5′-cccaagcttctttaatcgcctggtggtat-3′
CHIKV E1 5′-ccgCTCGAGatgtacgaacacgtaacagtg-3′ 5′-cccAAGCTTgtgcctgctaaacgacacgc-3′
Human IL-6 5′-gtagtgaggaacaagccagag-3′ 5′-ggactgcaggaactccttaaa-3′
Human COX-2 5′-gacagtccaccaacttacaat-3′ 5′-catctctccatcaattatctgat-3′
Human MBL 5′-ccgctcgagatgtccctg-3′ 5′-cccaagcttgatagg-3′
Human IL-1β 5′-catgggataacgaggcttatgt-3′ 5′-cccaaggccacaggtattt-3′
Human IL-8 5′-actgagagtgattgagagtggac-3′ 5′- aaccctctgcacccagttttc-3′
Human PLA-2 5′-ctacctacgttgctggtctttc-3′ 5′-ccaaataagtcgggagccataa-3′
Human TNF-α 5′-atcctgggggacccaatgtag-3′ 5′-gagcttcttcccacccacaag-3′
Human GAPDH 5′-accacagtccatgccatcac-3′ 5′-tccaccaccctgttgctgt-3′
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was amplified using the cDNA as a template. The
primers used for PCR reactions are indicated in Table 1.
To identify the selected CHIKV isolate, the 1317 base pair
CHIKV E1 envelope glycoprotein gene (E1) was amplified
using the primers in Table 1. An amplicon was cloned into
pJET 1.2/blunt cloning vector (Thermo Fisher Scientific,
USA) and sequenced using an ABI 3730XL DNA Analyzer
(Thermo Fisher Scientific, USA).
Sequence analysis
The E1 nucleotide sequence of the selected CHIKV isolate
was analyzed using NCBI BLASTX. Comparison of E1
amino acid sequence from the selected CHIKV isolate,
V-181, and the parental V-181 strain (AF15561) was
performed using ClustalW2 software [24].
Virus infection studies in 293T cells
293T cells were infected with either CHIKV T-SBY or
the V-181 strain at a MOI of 10 as described above.
Unbound virus was removed and the cells were exten-
sively washed thrice with DMEM supplemented with 2 %
heat-inactivated FBS, 25 mM HEPES, 2 mM L-glutamine,
and 0.37 % NaH2CO3. Freshly medium was added to the
infected 293T cells. Medium was collected to measure
viral load and RNA copy number at early (0, 2, 4, 6, and
12 h) and late (1, 2, 3, 4, 7, and 10 days) infection using a
standard plaque assay and quantitative real-time PCR
(qRT-PCR). Standard plaque assay and qRT-PCR were
performed in three independent experiments.
Indirect immunofluorescence assay
293T cells were infected with either CHIKV T-SBY or
the V-181 strain at a MOI of 10 as previously described.
Three independent experiments were performed. The
infected cells were harvested at 0, 4, 7 and 10 d.p.i. by
removing the infected 293T cell medium and gently
washed the infected cells with Phosphate Buffer Saline
(PBS) twice. The cells were detached using 0.25 %
Trypsin-EDTA and washed with PBS at 1,500xg, at room
temperature for 3 min thrice. Cell pellets were resus-
pended in PBS and smeared on a coverslip before air-
drying at room temperature for 10 min. The cells were
fixed with 4 % paraformaldehyde in PBS for 20 min at
room temperature and washed with PBS. The cells were
permeabilized with 0.1 % Triton X-100 in PBS for
15 min at room temperature and washed with PBS
thrice. The cells were then incubated with 5 % normal
goat serum in PBS with 0.05 % Tween 20 for 1 h at
room temperature. Subsequently, the cells were incu-
bated with a mouse anti-CHIKV monoclonal antibody
(Thermo Fisher Scientific, USA) at a dilution of 1:10 at
room temperature for 1 h. After washing with PBS
thrice, the cells were incubated with a 1:100 dilution of a
fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG polyclonal antibody (Thermo Fisher Scien-
tific, USA). The cells were washed with PBS thrice and
incubated with 500nM propidium iodide (PI) (Invitrogen,
Ltd.) in PBS in the dark for 30 min at room temperature.
After a brief wash with PBS, the cells were mounted with
a mounting medium, covered with coverslips and sealed
with nail polish. CHIKV infected 293T cells were observed
under an Olympus DP-72 fluorescence microscope.
To determine the level of cell infection, CHIKV infected
293T cells were counted from five different microscopy
fields in three independent experiments using ImageJ
1.49v software (National Institutes of Health, USA).
Cell viability assay
Cell viability was measured using a classical MTT assay
[25]. 293T cells were infected with either CHIKV T-SBY
or the V-181 strain at MOI of 10 as previously described.
Three independent experiments were performed. Infected
cells were assessed for cell viability for 10 days on a daily
basis. The infected 293T cell medium was removed and
replaced with fresh medium. MTT (3-(4,5-Dimethyl-
thiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) was added
to a final concentration of 1.3 mM and incubated at 37 °C
for 4 h in a humidified chamber. The medium was re-
moved and crystals were solubilized by adding dimethyl
sulfoxide (DMSO) and incubating at 37 °C for 10 min.
The samples were measured for absorbance using an
ELISA reader at a wavelength of 570 nm.
Quantitative real-time polymerase chain reaction
Quantitative real-time reverse transcription PCR (qRT-
PCR) was used to determine viral RNA copy number
and relative levels of cytokine gene expression. Superna-
tants from early (0, 2, 4, 6, and 12 h) and late (1, 2, 3, 4,
7, and 10 days) infections were prepared as described
before. Viral RNAs were extracted by High Pure Viral
RNA Kit (Roche, USA) and converted to cDNA using
the RevertAid First Strand cDNA Synthesis Kit (Thermo
Fisher Scientific, USA). The viral non-structural protein
1 gene (nsp1) was amplified using primers indicated in
Table 1. Quantitative PCR analysis was performed using
Luminaris Color HiGreen qPCR Master Mix, low ROX
(Thermo Fisher Scientific, USA) as previously described
[26]. The viral RNA copy number per ml was calculated.
All quantitative PCR results were checked for specificity
by melting curve analysis.
For cytokine gene expression, 293T cells were infected
with either CHIKV T-SBY or the V-181 strain at a MOI of
10. Infected cells were harvested at 0, 4, and 7 d.p.i. and
RNA was extracted using TRIzol reagent (Invitrogen,
USA). RNA was used as a template for reverse-
transcriptase polymerase chain reaction (RT-PCR) using
the RevertAid First Strand cDNA Synthesis Kit (Thermo
Fisher Scientific, USA). The primers used for PCR
Chalaem et al. Virology Journal  (2016) 13:150 Page 4 of 12
reactions are indicated in Table 1. The qRT-PCR was
performed by Luminaris Color HiGreen qPCR Master
Mix, low ROX (Thermo Fisher Scientific, USA). The tar-
get transcripts were normalized to the number of
GAPDH transcripts for quantitative analysis of gene
expression. Melting curve analysis was performed to
checking for specificity.
Statistical analysis
Results are expressed as the mean ± standard error of
the mean (SEM). The significance of the difference
between the mean values of the groups was evaluated by
two-tailed Student’s t test.
Results
Isolation of a chikungunya virus isolate from human serum
To contribute to the biology and virulence of infectious
CHIKV, we sought to isolate an infectious strain from
human patients. To accomplish this, we collected
banked serum samples from five patients from the 2009
outbreak in the Songkhla Province, Thailand, who were
with tested negative for the presence of dengue virus
(DENV) and yellow fever virus, as assessed by routine
PCR analysis. CHIKV was isolated from each patient
serum using standard procedures as detailed in the Ma-
terials and Methods section. The patients sera were in-
oculated in Aedes albopictus C6/36 cells and single
clones were obtained by serial dilution before further
propagation in Vero cells. After infection of the cells
with five different isolates at a multiplicity of infection
(MOI) of 10, plaque morphology and cytopathic effect
(CPE) for each isolate was compared. The viral clone
with highest plaque size and that induced most CPE
virulence was selected for further study. To identify the
strain of the selected CHIKV isolate, we synthesized
cDNA from the viral RNA and amplified by PCR the
1317 base pair CHIKV E1 envelope glycoprotein gene,
which is usually used for identification of CHIKV
strains and their phylogenetic analysis. Comparison of
the E1 nucleotide sequence using NCBI BLASTX re-
vealed a close match with the E1 protein of the Indo-
nesian CHIK/SBY8/10 isolate (GenBank accession
number AB678677) with 100 % identity at the amino
acid level and an E value of 0. Phylogenetic analysis of
the E1 nucleotide sequence and the E1 sequences avail-
able in GenBank confirmed that the selected isolate
belonged to the Asian genotype. It clustered within a
clade of Indonesian sequences collected between 2008
and 2010 (Fig. 1). Hereinafter, we refer to this selected
Thailand CHIKV isolate as T-SBY.
Assessment of growth and release of T-SBY from 293T cells
We next studied the growth and release of the isolated
virus in comparison with a well-studied CHIKV vaccine
strain, called 181/clone 25, herein abbreviated as V-181.
Of note, the vaccine strain V-181 (GenBank accession
number L37661) was derived from the CHIKV parental
strain AF15561 (GenBank accession number EF452493)
as described in [27]. Analysis of the E1 envelope glycopro-
tein from the currently isolated strain, T-SBY, the vaccine
strain V-181, and its parental strain AF15561 using Clas-
talW2 software [24] revealed two conservative amino acid
substitutions at positions 142 and 145, from isoleucine
(ATC) to valine (GTT), and alanine (GCT) to serine
(TCT), respectively. Additionally, substitutions of three
semi-conservative amino acids at positions, 304, 397,
and 404 for serine (TCA) to proline (CCA), proline
(CCC) to leucine (CTC), and alanine (GCT) to valine
(GTT) were observed (Fig. 2). Note that the amino acid
sequence of V-181 E1 envelope glycoprotein differs in a
single amino acid substitution at position 404, from val-
ine to alanine from the parental strain, AF15561 [27].
As CHIKV can infect several types of cell lines [26, 28],
we selected one of the permissive cells for chikungunya
virus infection that support virus growth better when
compare with other cell types, 293T cells. Notably, the
293T cells also are easy culture and maintain in labora-
tory conditions and are considered as a model cell line
for various studies. We therefore, selected the 293T
cells, as a model in this study. To examine the growth
and release of the isolated virus in comparison with
CHIKV V-181, we determined the viral load and RNA
copy number at different time points following infec-
tion of 293T cells (Fig. 3). The cells were exposed to ei-
ther CHIKV T-SBY or V-181 strain for 2 h at a MOI of
10. The culture was washed extensively to remove any
unbound virus. The viral load was determined in the
supernatant from three independent experiments at
early time points (0, 2, 4, 6, and 12) hours post infec-
tion (h.p.i.) as well as during late time points (1, 2, 3, 4,
7, and 10) days post infection (d.p.i.) using standard
plaque assay as described in Materials and Methods.
The results showed that in the first 2 h.p.i. there was
no detection of infectious virus from cells infected with
either strain, further testifying complete removal of
virus in the supernatant. However, the levels of newly
produced progeny viruses were gradually increased in
the supernatants after 4 h.p.i, reaching the maximum
levels of ~104 and ~8 × 103 PFU/ml in CHIKV T-SBY and
V-181 strains, respectively, after 7 d.p.i. No statistically sig-
nificant was observed. Thereafter, the viral levels de-
creased at 10 d.p.i, and no virus in supernatants could be
detected at 15 and 20 d.p.i. (data not shown). At all post
infection periods, the T-SBY levels were higher than the
V-181 although statistically significant differences were re-
corded at 1, 2, and 4 d.p.i. (Fig. 3a).
In a parallel set of experiments, we also quantified
viral RNA in the supernatant from three independent
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experiments at early post infection (0–12 h.p.i.) and late
post infection (1–10 d.p.i.) using an established real-time
PCR assay [26]. We did not normalize the virus RNA
copies with cell GAPDH copy number as such
normalization would be biased by the state of cellular
transcription or GAPDH levels in the cell. There are
likely to be a substantial fraction of infected cells with a
high virus titer but with limited transcription or
Fig. 1 Molecular phylogenetic analysis by Maximum Likelihood method. The evolutionary history was inferred by using the Maximum Likelihood
method based on the Tamura-Nei model [38]. The tree with the highest log likelihood (-4636.3022) is shown. The percentage of trees in which
the associated taxa clustered together is shown next to the branches. Initial tree(s) for the heuristic search were obtained automatically by
applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL)
approach, and then selecting the topology with superior log likelihood value. The analysis involved 65 nucleotide sequences. All positions
containing gaps and missing data were eliminated. There were a total of 1,317 positions in the final dataset. Evolutionary analyses were
conducted in MEGA7 [39]. Asterisk (*) indicates the selected isolate from this study. Double asterisk (**) indicates the comparable strain in this
study. Triple asterisk (***) indicates the parental strain of the comparable strain
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degraded GAPDH levels. The result was overall consist-
ent with virus release in supernatant with only minor
differences (Fig. 3b). The viral RNA copies could be de-
tected in both infectious T-SBY and V-181 supernatants
at 2 h.p.i. with 28 ± 1 and 35 ± 6 viral RNA copies/ml in
infectious T-SBY and V-181 supernatants, respectively.
The amount of viral RNA copies gradually increased
and reached the peak level of greater than 104 RNA
copies/ml in both T-SBY and V-181 infected superna-
tants at 7 d.p.i, and then declined at 10 d.p.i. The num-
ber of T-SBY viral RNA copies was consistently higher
than that of V-181 at almost all post infection time
points with statistically significant differences at
12 h.p.i. and 7 d.p.i. (Fig. 3b). Similar to the plaque
assay, no viral RNA in supernatants could be detected
at 15 and 20 d.p.i. (data not shown).
Fig. 2 Multiple sequence alignment of CHIKV E1 envelope glycoprotein (E1). The 1,317 base pair CHIKV E1 envelope glycoprotein gene from the
isolated CHIKV was amplified by PCR. Comparison of the E1 nucleotide sequence using NCBI BLASTX revealed a close match with the E1 protein
in the CHIK/SBY8/10 isolate from Indonesia (GenBank accession number AB678677; T-SBY). Amino acid sequences of the E1 from T-SBY were
aligned with E1 from the 181/clone 25 vaccine strain (GenBank accession number L37661; V-181) and its parental strain AF15561 (GenBank
accession number EF452493) [27] using ClastalW2 software [24]. Asterisks (*) indicate completely identical amino acids. An alteration of amino
acid residues is shaded in grey. Single (.) and double dot (:) represent semi-conservative and conservative amino acid substitution
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Cytopathic effect of T-SBY in 293T cells
To compare the development of infection of CHIKV T-
SBY with that of V-181, 293T cells were infected with ei-
ther strain at a MOI of 10. Cytopathic effects (CPE) were
observed under light microscopy daily for 10 days (data
not shown) when cells became most infected, as revealed
by the highest immunoreactivity (Fig. 4a). By 3 d.p.i.,
about 10 ± 0.7 and 3 ± 0.5 % of total infected T-SBY and
V-181 cell number became swollen, respectively. The
increase of cell diameter continued within the next day,
accounting for an additional increase of 25 ± 1.5 and
10 ± 2 % at 4 d.p.i, respectively. In addition, the infected
cells detached from the surface of the culture plate with
formation of small black spot in the cells (Fig. 4b). Not-
ably, at all time points these spots were more pronounced
in cells infected with T-SBY than in those infected with
V-181. The amount of swelled and detached cells and
black spot formation continued to increase until they
reached 80 ± 5.0 and 60 ± 2.5 % in cultures infected
with T-SBY and V-181, respectively, by 10 d.p.i. There-
fore, in summary, the cells infected with T-SBY were
more swelled and detached more quickly, compared to
cells infected with V-181.
To visualize the development of infection, 293T cells
were infected with either CHIKV T-SBY or V-181 at a
MOI of 10 and processed for an immunofluorescence
assay with a mouse anti-CHIKV monoclonal antibody at
0, 4, 7, and 10 d.p.i. At 4 d.p.i., about 34 ± 2 and 22 ± 3 %
of the cells infected with CHIKV T-SBY and V-181 strains,
respectively, showed expression of the viral antigen
(Fig. 4c). By 7 d.p.i., infection could be detected in
approximately ~100 and ~91 % of cells infected with
CHIKV T-SBY and V-181 strains, respectively. No sta-
tistically significant difference was observed.
We also determined cell viability with a classical MTT
assay as described in Materials and Methods. The cells
were infected with either CHIKV T-SBY or V-181 at a
MOI of 10. The viability of the infected cells was deter-
mined daily for 10 days. The viability of cells infected with
CHIKV T-SBY was lower than that of cells infected with
V-181 cells starting at 2 d.p.i. with statistically significant
(*p < 0.05) at 4 and 5 d.p.i., and highly statistically signifi-
cant differences (**p < 0.001) from 6 to 10 d.p.i. (Fig. 4d).
Expression of cytokines during T-SBY infection of 293T cells
As previous results suggest that the our T-SBY strain
isolated from a patient is more infectious and induces
stronger cytopathic effects upon infection of 293T cell
than the vaccine strain V-181, we were interested to
examine virus-induced inflammatory cellular responses
[26, 29]. CHIKV is known to induce cellular inflammatory
responses and the level of certain cytokines in CHIKV-
infected patient serum has been shown to correlate with
the symptomatic phase of infection. We therefore wanted
to study the expression of selected cytokine genes that
were previously shown to be activated during symptom-
atic phase of CHIKV infection and involved in the genesis
of inflammatory host responses, including rheumatoid
arthritis (RA) [30]. 293T cells were infected with either
CHIKV T-SBY or V-181 at a MOI of 10. Total RNA was
isolated from infected cells at 0, 4, and 7 d.p.i. Transcrip-
tion levels of Interleukin-6 (IL-6), Cyclooxygenase-2
(COX-2), Mannose binding lectin (MBL), Interleukin1-
beta (IL1-β), Interleukin-8 (IL-8), Phospholipase A2
(PLA-2), and Tumour necrosis factor alpha (TNF-α)
were measured using quantitative RT-PCR and normal-
ized per GAPDH transcripts. Results showed that both
viruses induced expression of all examined cytokine or
inflammation-related genes. Although levels of induc-
tion of cellular inflammatory responses were similar for
Fig. 3 CHIKV release from 293T cells. 293T cells were exposed to
either CHIKV T-SBY or V-181 for 2 h at a MOI of 10. Unbound virus
was removed and washed extensively. Supernatants were collected
for determination of viral loads (a) and viral RNA (b) at early (0, 2, 4,
6, and 12 h) and late (1, 2, 3, 4, 7, 10 d) infection using standard
plaque assay and real time PCR as described in Materials and
Methods. Results are expressed as viral titer (PFU/ml) (a) and viral
RNA copies/ml (b). The bars represent the mean values and the
error bars represent the SEM values from three independent
experiments. Asterisks (*) indicate p < 0.05
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both viruses, statistically significant higher expression
of COX-2, MBL, and IL-6 was observed in cells infected
with T-SBY at 4 and 7 d.p.i. (Fig. 5). Although the precise
mechanisms of how these two CHIKV strains induce cel-
lular inflammatory responses or biological significance of
their noticeably different cytokine response profiles awaits
future investigation, our study further underscores the
utility of 293T cells for studying the biology and cellular
responses to CHIKV infection.
Discussion
Chikungunya virus (CHIKV) is one of the recently emer-
ging and re-emerging serious mosquito-borne pathogen
that can elicit significant human morbidity in many
parts of the world [1]. The virus is responsible for recent
large-scale epidemics in many tropical and sub-tropical
countries, including one in the southern provinces of
Thailand, where 49,069 human cases were reported in
little over a year between 2008–2009 [20]. Notably, sub-
sequent studies identified variations among the Thai iso-
lates, including clones harbouring unique amino acid
substitutions close to the immunodominant site [21].
Compared to many other arthropod-borne infective
agents, CHIKV is relatively less well studied, which is
now considered as an important neglected tropical dis-
ease [31]. While recently significant efforts were directed
towards a better understanding of the biology, infectivity
and pathogenesis of CHIKV infection, as a new health
global risk, including 693,489 suspected cases reported
alone in the Americas in 2015 [32], further studies on
the biology and virulence of CHIKV remain warranted,
especially those focused on the virus isolated from pa-
tients from recent epidemics. In this report, we isolated
a CHIKV strain from patients’ sera banked from the
2008–2009 Thai epidemics. We identified this virus is
closely related to the Asian genotype, CHIK/SBY8/10
isolate originally found in patient’s blood in Indonesia
[33]. To the best of our knowledge, no prior study ad-
dressed the characterization, replication, and release of
the strain used in our study. Therefore, our study likely
represents the first characterization of this clinical strain.
We used 293T cells as in vitro model for studying viral
growth kinetics, inflammatory cellular responses, and virus-
induced cytopathic effects. Based on the release of viral par-
ticles in the supernatants or measurement of viral mRNA
from supernatants, viral replication could be detectable
Fig. 4 CHIKV infection of 293T cells. (a) 293T cells were infected with either CHIKV T-SBY or V-181 at MOI of 10. Infected cells at 0, 4, 7, and 10
d.p.i. were collected and stained with antibody against CHIKV and FITC-labeled secondary antibodies to visualize the infected cells at 0, 4, 7, and
10 d.p.i. (b) 293T cells were infected with either CHIKV T-SBY or V-181 as described in panel A. Infected cells were collected and stained with
propidium iodide (PI) to visualize the nuclei prior examination under a fluorescence microscope. Foci were observed at 0, 4, 7, and 10 d.p.i. (c)
293T cells were infected as detailed in panel A. Infected cells at 0, 4, 7, and 10 d.p.i. were collected and labeled with an anti-CHIKV monoclonal
antibody followed by an appropriated FITC-labeled secondary antibody as well as propidium iodide (PI) to visualize the nuclei prior examination
under a fluorescence microscope. Quantification of CHIKV infected cells were analyzed using ImageJ 1.49v software after immunostaining. Three
independent experiments were performed and the bars represent the mean values and the error bars represent the SEM values. The amount of CHIKV
T-SBY infected cells was statistically significantly higher (*p < 0.05) at 4 and 7 d.p.i. (d) Analysis of cell viability using a classical MTT assay. The 293T cells
were exposed with either CHIKV T-SBY or V-181 for 2 h at an MOI of 10. Infected cells were assessed for cell viability during 10 days on a daily basis.
The bars represent the mean values and the error bars represent the SEM values from three independent experiments. The difference in cell viability in
CHIKV T-SBY infected cells was statistically significant (*p < 0.05) at 4 and 5 d.p.i., whilst it was highly significant (**p < 0.001) at 6 d.p.i.
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within 4 h of infection, and continued to increase grad-
ually peaking at 7 days. A massive detachment of CHIKV-
infected cells after 10 days post-infection suggested virus-
induced cell death, possibly via apoptosis as reported in
Vero cells [26, 28]. The decline of virus titer or RNA cop-
ies at 10 d.p.i. clearly demonstrated a decrease of viral rep-
lication, which may be due to the lysis or death of infected
host cells. Similarly, due to absence of viable cells support-
ing growth of CHIKV, undetectable virus titer or RNA
copies at 15 and 20 d.p.i. likely indicated disappearance of
the virus.
Based on the growth kinetics, microscopic observation,
CPE, and cell viability T-SBY is more virulent than the
vaccine strain V-181 used in our study. A single amino
acid alteration in the E1 surface glycoprotein was shown
to have profound effects on CHIKV host tropism [27],
we found 4 amino acid changes in the E1 protein
between T-SBY and the vaccine strain V-181 which can
Fig. 5 Expression of cytokine gene candidates during CHIKV infection of 293T cells. The relative expression levels of IL-6, COX-2, MBL, IL1-β, IL-8,
PLA-2, and TNF-a during CHIKV infection of 293T cells were analyzed. Transcript levels of candidate genes were measured using quantitative
RT-PCR and presented as copies of target transcripts per copy of the GAPDH transcripts. RNA was isolated from CHIKV infected cells at 0, 4, and 7 d.p.i.
The bars represent the mean values and the error bars represent the SEM values from six quantitative RT-PCR analyses of two independent cell
infection experiments. The relative expression levels of IL-6 and MBL in CHIKV T-SBY infected cells were statistically significantly higher (*p < 0.05) at 7
and 4 d.p.i., respectively, whilst the difference in the relative expression levels of COX-2 was highly significant (**p < 0.001) at 4 d.p.i.
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explain why T-SBY is more virulent, however the pre-
cise role of any of these substitutions as well as the
potential input of the differences in other viral proteins
awaits further investigation.
The arthritogenic potential of CHIKV is associated
with its ability to persist in the joint tissue and induce
the production of proinflammatory cytokines. Indeed,
CHIKV infection induces a potent inflammatory cyto-
kine and immunomodulatory response in patients, with
more severe disease associated with increased plasma
levels of several proinflammatory cytokines [11], particu-
larly IL-6 [34]. Many of these cytokines are associated
with the pathogenesis of systemic inflammatory disease,
such as rheumatoid arthritis [35, 36], which is one of the
most serious clinical complications of CHIKV fever. We
therefore, also examined the induction of several cytokines
and immunomodulators in 293T cells. The majority of
these cytokines and immunomodulators displayed a grad-
ually enhanced transcription during the course of 293T
cell infection, which correlated with increased viral loads.
While the induction of these proinflammatory modulators
by the two different CHIKV isolates was very similar, the
expression of IL-6 and COX-2, was statistically signifi-
cantly higher during infection with the more virulent
isolate, T-SBY, especially late during infection (between
day 4–7). While induction of COX-2 is known to be
transient and its pro-inflammatory role remains contro-
versial [37], our study suggests a possible contribution
of this immunomodulator to enhanced virulence of at
least some CHIKV isolates.
Conclusions
In summary, we describe the successful isolation of a
CHIKV strain, which was identified based on the E1
envelop glycoprotein sequence. The isolated virus is
closely related to the CHIKV isolate SBY8/10 identified
in patients in Indonesia. We determined that 293T cells
are an excellent cell culture model of CHIKV SBY8/10
that supports viral replication, development of CPE
and subsequent cell death. We also determined expression
of proinflammatory cytokines and immunomodulatory
molecules upon CHIKV infection of 293T cells, which can
be involved in CHIKV-induced immune responses and
contribute to the immunopathology of the viral infection.
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